Xu Shanshan, Song Zhihui, Cheng Xiao, Wang Jiawei
Department of Pharmacy, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Front Allergy. 2025 Mar 5;6:1503597. doi: 10.3389/falgy.2025.1503597. eCollection 2025.
Few studies have tested the feasibility and efficacy of WeChat-based asthma self-management, which supports patients in managing their asthma via mobile phone. We developed an intervention program based on the WeChat Mini program to support self-management. We evaluated the effectiveness and feasibility of improving asthma control and quality of life in patients with asthma.
Fifty and 53 patients were randomized into the control and WeChat groups, respectively, to receive traditional interventions and interventions based on the WeChat Mini program. We conducted the intervention for three months and then observed for three months.
At the end of the third month, the Asthma Control Test (ACT) scores of the WeChat group were greater than those of the control group ( = 0.003), and the ACT scores of the two groups were significantly higher than those at baseline ( = 0.028; < 0.001). At the end of the sixth month, the control group was not significantly different from the baseline group ( = 1.000), but the WeChat group was significantly different ( < 0.001). The ACT scores of the WeChat group were higher than those of the control group ( = 0.001). The ACT scores of the WeChat group were lower than those of the third month, but the difference was insignificant ( = 0.214). For asthma self-management and quality of life, the WeChat group improved more at the end of the third and sixth months (all < 0.001).
Implementing an asthma self-management program based on the WeChat application is effective in helping patients with asthma improve their asthma control and quality of life.
很少有研究测试基于微信的哮喘自我管理的可行性和有效性，该管理方式通过手机支持患者管理哮喘。我们基于微信小程序开发了一个干预项目以支持自我管理。我们评估了改善哮喘患者哮喘控制和生活质量的有效性和可行性。
分别将50名和53名患者随机分为对照组和微信组，以接受传统干预和基于微信小程序的干预。我们进行了三个月的干预，然后观察三个月。
在第三个月末，微信组的哮喘控制测试（ACT）得分高于对照组（=0.003），两组的ACT得分均显著高于基线时的得分（=0.028；<0.001）。在第六个月末，对照组与基线组无显著差异（=1.000），但微信组有显著差异（<0.001）。微信组的ACT得分高于对照组（=0.001）。微信组的ACT得分低于第三个月，但差异不显著（=0.214）。对于哮喘自我管理和生活质量，微信组在第三个月和第六个月末改善得更多（均<0.001）。
实施基于微信应用的哮喘自我管理项目可有效帮助哮喘患者改善哮喘控制和生活质量。
